Growth Metrics

Alnylam Pharmaceuticals (ALNY) FCF Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 723.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,066.00
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6,066.00
Dec 31, 2025 3,868.00
Sep 30, 2025 7,339.00
Jun 30, 2025 8,678.00
Mar 31, 2025 -34,676.00
Dec 31, 2024 2,477.00
Sep 30, 2024 8,924.00
Jun 30, 2024 8,383.00
Mar 31, 2024 11,988.00
Dec 31, 2023 7,828.00
Sep 30, 2023 14,314.00
Jun 30, 2023 12,270.00
Mar 31, 2023 21,069.00
Dec 31, 2022 12,687.00
Sep 30, 2022 26,228.00
Jun 30, 2022 -59,479.00
Mar 31, 2022 52,117.00
Dec 31, 2021 118,251.00
Sep 30, 2021 617,770.00
Jun 30, 2021 35,445.00
Mar 31, 2021 67,107.00
Dec 31, 2020 23,783.00
Sep 30, 2020 62,803.00
Jun 30, 2020 49,842.00
Mar 31, 2020 45,266.00
Dec 31, 2019 23,002.00
Sep 30, 2019 38,989.00
Jun 30, 2019 151,084.00
Mar 31, 2019 65,647.00
Dec 31, 2018 -48,098.00
Sep 30, 2018 -530,094.00
Jun 30, 2018 23,380.00
Mar 31, 2018 -65,488.00
Dec 31, 2017 -15,916.00
Sep 30, 2017 -32,544.00
Jun 30, 2017 1,991.00
Mar 31, 2017 -21,153.00
Dec 31, 2016 -20,392.00
Sep 30, 2016 -44,994.00
Jun 30, 2016 -70,601.00
Mar 31, 2016 -124,695.00
Dec 31, 2015 -581.00
Sep 30, 2015 -95,900.00
Jun 30, 2015 -54,120.00
Mar 31, 2015 -497.00
Dec 31, 2014 -4,165.00
Sep 30, 2014 -25,924.00
Jun 30, 2014 -53,329.00
Mar 31, 2014 -47,801.00
Dec 31, 2013 -7,729.00
Sep 30, 2013 -16,135.00
Jun 30, 2013 -17,934.00
Mar 31, 2013 5,312.00
Dec 31, 2012 -66,987.00
Sep 30, 2012 8,486.00